Summary

The global companion animal health market is expanding steadily as pet ownership rises and awareness regarding animal healthcare improves worldwide. Companion animals such as dogs, cats, birds, and horses are increasingly viewed as part of the family, prompting owners to invest more in their health, nutrition, and overall well-being. The market includes a broad spectrum of offerings, including therapeutics, diagnostics, vaccines, and preventive care solutions designed to enhance the quality of life of pets. Continuous advancements in veterinary science and the growing focus on animal welfare are shaping a favorable environment for sustained market growth.

Market Insights

The companion animal health market is expected to reach USD 28.6 billion in 2026 and is projected to grow to USD 57.1 billion by 2033, registering a CAGR of 10.40% over the forecast period. This growth reflects the increasing demand for advanced veterinary care and the rising adoption of innovative healthcare solutions for pets. The market is also benefiting from increased spending on pet healthcare, growing awareness of preventive treatments, and the expansion of veterinary infrastructure. Furthermore, the introduction of advanced diagnostic tools and biologics is supporting the overall development of the market.

Market Drivers

A major factor driving the growth of the companion animal health market is the increasing trend of pet humanization. Pet owners are now more inclined to spend on high-quality medical treatments, regular check-ups, and preventive care for their animals. This shift has significantly boosted demand for veterinary pharmaceuticals, diagnostics, and specialized treatments.

The rising incidence of chronic and infectious diseases among companion animals is another important growth driver. Conditions such as obesity, arthritis, and skin disorders are becoming more prevalent, leading to a greater need for ongoing medical care and monitoring. This has created a strong demand for therapeutic products and advanced diagnostic solutions.

Technological progress in veterinary medicine is further supporting market growth. Innovations such as rapid diagnostic tests, molecular diagnostics, and tele-veterinary services are improving the efficiency and accuracy of disease detection and treatment. Additionally, pharmaceutical companies are investing heavily in research and development to introduce new and effective treatment options for companion animals.

Business Opportunity

The market presents significant opportunities for companies involved in animal healthcare. One key opportunity lies in the development of biologics and targeted therapies that offer improved treatment outcomes with fewer side effects. As research in animal health advances, personalized medicine for pets is gaining traction and is expected to become a major growth area.

Another important opportunity is the expansion of veterinary diagnostic services. Early detection of diseases is becoming a priority for pet owners, creating demand for innovative and easy-to-use diagnostic tools. Portable diagnostic devices and point-of-care testing solutions are particularly gaining popularity in both developed and emerging markets.

Digital transformation is also opening new growth avenues. The use of telemedicine, mobile applications, and data analytics in veterinary care is improving accessibility and convenience for pet owners. These technologies are enabling remote consultations, real-time health monitoring, and better disease management.

Emerging markets in Asia Pacific and Latin America offer considerable growth potential due to increasing urbanization, rising disposable incomes, and growing pet adoption rates. Companies that focus on expanding their presence in these regions can capitalize on the untapped opportunities.

Region Analysis

North America holds a leading position in the companion animal health market due to high pet ownership rates and strong spending on pet healthcare. The region benefits from well-established veterinary infrastructure and the presence of major industry players. Advanced diagnostic technologies and a high level of awareness among pet owners further support market growth.

Europe is also a significant market, driven by increasing awareness of animal welfare and supportive government regulations. Countries such as Germany, the United Kingdom, and France are experiencing steady growth in veterinary services and pet healthcare spending.

The Asia Pacific region is expected to witness the fastest growth during the forecast period. Rapid urbanization, changing lifestyles, and increasing disposable incomes are encouraging pet adoption in countries like China, India, and Japan. Improved veterinary facilities and growing awareness of preventive care are contributing to the expansion of the market in this region.

Latin America and the Middle East & Africa are gradually emerging as important markets. Rising pet ownership and improving access to veterinary care are driving growth, although challenges related to affordability and infrastructure still exist in some areas.

Key Players

• Zoetis Inc.

• Boehringer Ingelheim

• Elanco Animal Health Incorporated

• Merck Animal Health

• Virbac

• IDEXX Laboratories, Inc.

• Ceva Santé Animale

• Vetoquinol S.A.

• Dechra Pharmaceuticals PLC

• Mars Petcare Inc.

• PetIQ, Inc.

• Phibro Animal Health Corporation

• HIPRA

• Agrolabo S.p.A.

• Neogen Corporation

Conclusion

The companion animal health market is poised for strong growth, supported by increasing awareness, technological advancements, and rising investments in veterinary healthcare. As pets continue to be treated as family members, the demand for high-quality healthcare solutions is expected to grow significantly. Companies that focus on innovation, accessibility, and expanding their global footprint are likely to benefit from the evolving market landscape.

Segmentation

By Animal Type

• Canine

• Feline

• Equine

• Avian

• Others

By Product Type

• Therapeutics

• Diagnostics

By Geography

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Companion Animal Health Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Five Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global Companion Animal Health Market Outlook, 2020 - 2033
3.1. Global Companion Animal Health Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
3.1.1. Canine
3.1.2. Feline
3.1.3. Equine
3.1.4. Avian
3.1.5. Others
3.2. Global Companion Animal Health Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
3.2.1. Therapeutics
3.2.2. Diagnostics
3.3. Global Companion Animal Health Market Outlook, by Region, Value (US$ Bn), 2020-2033
3.3.1. North America
3.3.2. Europe
3.3.3. Asia Pacific
3.3.4. Latin America
3.3.5. Middle East & Africa
4. North America Companion Animal Health Market Outlook, 2020 - 2033
4.1. North America Companion Animal Health Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
4.1.1. Canine
4.1.2. Feline
4.1.3. Equine
4.1.4. Avian
4.1.5. Others
4.2. North America Companion Animal Health Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
4.2.1. Therapeutics
4.2.2. Diagnostics
4.3. North America Companion Animal Health Market Outlook, by Country, Value (US$ Bn), 2020-2033
4.3.1. U.S. Companion Animal Health Market Outlook, by Animal Type, 2020-2033
4.3.2. U.S. Companion Animal Health Market Outlook, by Product Type, 2020-2033
4.3.3. Canada Companion Animal Health Market Outlook, by Animal Type, 2020-2033
4.3.4. Canada Companion Animal Health Market Outlook, by Product Type, 2020-2033
4.4. BPS Analysis/Market Attractiveness Analysis
5. Europe Companion Animal Health Market Outlook, 2020 - 2033
5.1. Europe Companion Animal Health Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
5.1.1. Canine
5.1.2. Feline
5.1.3. Equine
5.1.4. Avian
5.1.5. Others
5.2. Europe Companion Animal Health Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
5.2.1. Therapeutics
5.2.2. Diagnostics
5.3. Europe Companion Animal Health Market Outlook, by Country, Value (US$ Bn), 2020-2033
5.3.1. Germany Companion Animal Health Market Outlook, by Animal Type, 2020-2033
5.3.2. Germany Companion Animal Health Market Outlook, by Product Type, 2020-2033
5.3.3. Italy Companion Animal Health Market Outlook, by Animal Type, 2020-2033
5.3.4. Italy Companion Animal Health Market Outlook, by Product Type, 2020-2033
5.3.5. France Companion Animal Health Market Outlook, by Animal Type, 2020-2033
5.3.6. France Companion Animal Health Market Outlook, by Product Type, 2020-2033
5.3.7. U.K. Companion Animal Health Market Outlook, by Animal Type, 2020-2033
5.3.8. U.K. Companion Animal Health Market Outlook, by Product Type, 2020-2033
5.3.9. Spain Companion Animal Health Market Outlook, by Animal Type, 2020-2033
5.3.10. Spain Companion Animal Health Market Outlook, by Product Type, 2020-2033
5.3.11. Russia Companion Animal Health Market Outlook, by Animal Type, 2020-2033
5.3.12. Russia Companion Animal Health Market Outlook, by Product Type, 2020-2033
5.3.13. Rest of Europe Companion Animal Health Market Outlook, by Animal Type, 2020-2033
5.3.14. Rest of Europe Companion Animal Health Market Outlook, by Product Type, 2020-2033
5.4. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Companion Animal Health Market Outlook, 2020 - 2033
6.1. Asia Pacific Companion Animal Health Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
6.1.1. Canine
6.1.2. Feline
6.1.3. Equine
6.1.4. Avian
6.1.5. Others
6.2. Asia Pacific Companion Animal Health Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
6.2.1. Therapeutics
6.2.2. Diagnostics
6.3. Asia Pacific Companion Animal Health Market Outlook, by Country, Value (US$ Bn), 2020-2033
6.3.1. China Companion Animal Health Market Outlook, by Animal Type, 2020-2033
6.3.2. China Companion Animal Health Market Outlook, by Product Type, 2020-2033
6.3.3. Japan Companion Animal Health Market Outlook, by Animal Type, 2020-2033
6.3.4. Japan Companion Animal Health Market Outlook, by Product Type, 2020-2033
6.3.5. South Korea Companion Animal Health Market Outlook, by Animal Type, 2020-2033
6.3.6. South Korea Companion Animal Health Market Outlook, by Product Type, 2020-2033
6.3.7. India Companion Animal Health Market Outlook, by Animal Type, 2020-2033
6.3.8. India Companion Animal Health Market Outlook, by Product Type, 2020-2033
6.3.9. Southeast Asia Companion Animal Health Market Outlook, by Animal Type, 2020-2033
6.3.10. Southeast Asia Companion Animal Health Market Outlook, by Product Type, 2020-2033
6.3.11. Rest of SAO Companion Animal Health Market Outlook, by Animal Type, 2020-2033
6.3.12. Rest of SAO Companion Animal Health Market Outlook, by Product Type, 2020-2033
6.4. BPS Analysis/Market Attractiveness Analysis
7. Latin America Companion Animal Health Market Outlook, 2020 - 2033
7.1. Latin America Companion Animal Health Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
7.1.1. Canine
7.1.2. Feline
7.1.3. Equine
7.1.4. Avian
7.1.5. Others
7.2. Latin America Companion Animal Health Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
7.2.1. Therapeutics
7.2.2. Diagnostics
7.3. Latin America Companion Animal Health Market Outlook, by Country, Value (US$ Bn), 2020-2033
7.3.1. Brazil Companion Animal Health Market Outlook, by Animal Type, 2020-2033
7.3.2. Brazil Companion Animal Health Market Outlook, by Product Type, 2020-2033
7.3.3. Mexico Companion Animal Health Market Outlook, by Animal Type, 2020-2033
7.3.4. Mexico Companion Animal Health Market Outlook, by Product Type, 2020-2033
7.3.5. Argentina Companion Animal Health Market Outlook, by Animal Type, 2020-2033
7.3.6. Argentina Companion Animal Health Market Outlook, by Product Type, 2020-2033
7.3.7. Rest of LATAM Companion Animal Health Market Outlook, by Animal Type, 2020-2033
7.3.8. Rest of LATAM Companion Animal Health Market Outlook, by Product Type, 2020-2033
7.4. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Companion Animal Health Market Outlook, 2020 - 2033
8.1. Middle East & Africa Companion Animal Health Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
8.1.1. Canine
8.1.2. Feline
8.1.3. Equine
8.1.4. Avian
8.1.5. Others
8.2. Middle East & Africa Companion Animal Health Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
8.2.1. Therapeutics
8.2.2. Diagnostics
8.3. Middle East & Africa Companion Animal Health Market Outlook, by Country, Value (US$ Bn), 2020-2033
8.3.1. GCC Companion Animal Health Market Outlook, by Animal Type, 2020-2033
8.3.2. GCC Companion Animal Health Market Outlook, by Product Type, 2020-2033
8.3.3. South Africa Companion Animal Health Market Outlook, by Animal Type, 2020-2033
8.3.4. South Africa Companion Animal Health Market Outlook, by Product Type, 2020-2033
8.3.5. Egypt Companion Animal Health Market Outlook, by Animal Type, 2020-2033
8.3.6. Egypt Companion Animal Health Market Outlook, by Product Type, 2020-2033
8.3.7. Nigeria Companion Animal Health Market Outlook, by Animal Type, 2020-2033
8.3.8. Nigeria Companion Animal Health Market Outlook, by Product Type, 2020-2033
8.3.9. Rest of Middle East Companion Animal Health Market Outlook, by Animal Type, 2020-2033
8.3.10. Rest of Middle East Companion Animal Health Market Outlook, by Product Type, 2020-2033
8.4. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Zoetis Inc.
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. Boehringer Ingelheim
9.4.3. Elanco Animal Health Incorporated
9.4.4. Merck Animal Health
9.4.5. Virbac
9.4.6. IDEXX Laboratories, Inc.
9.4.7. Ceva Santé Animale
9.4.8. Vetoquinol S.A.
9.4.9. Dechra Pharmaceuticals PLC
9.4.10. Mars Petcare Inc.
9.4.11. PetIQ, Inc.
9.4.12. Phibro Animal Health Corporation
9.4.13. HIPRA
9.4.14. Agrolabo S.p.A.
9.4.15. Neogen Corporation
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations